| Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ... The Lancet Neurology 18 (12), 1091-1102, 2019 | 1702 | 2019 |
| May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension T Beaney, LM Burrell, RR Castillo, FJ Charchar, S Cro, A Damasceno, ... European heart journal 40 (25), 2006-2017, 2019 | 262 | 2019 |
| Frequency of complementary and alternative medicine utilization in hypertensive patients attending an urban tertiary care centre in Nigeria OC Amira, NU Okubadejo BMC complementary and alternative medicine 7, 1-5, 2007 | 258 | 2007 |
| AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders V Salpietro, CL Dixon, H Guo, OD Bello, J Vandrovcova, S Efthymiou, ... Nature communications 10 (1), 3094, 2019 | 201 | 2019 |
| Parkinson's disease in Africa: a systematic review of epidemiologic and genetic studies NU Okubadejo, JH Bower, WA Rocca, DM Maraganore Movement disorders: official journal of the Movement Disorder Society 21 (12 …, 2006 | 182 | 2006 |
| Integrated and patient-centred management of Parkinson's disease: a network model for reshaping chronic neurological care BR Bloem, EJ Henderson, ER Dorsey, MS Okun, N Okubadejo, P Chan, ... The Lancet Neurology 19 (7), 623-634, 2020 | 167 | 2020 |
| Prevalence and clinical characteristics of headache in medical students of the University of Lagos, Nigeria FI Ojini, NU Okubadejo, MA Danesi Cephalalgia 29 (4), 472-477, 2009 | 154 | 2009 |
| Prevalence of stroke in an urban, mixed-income community in Lagos, Nigeria M Danesi, N Okubadejo, F Ojini Neuroepidemiology 28 (4), 216-223, 2007 | 154 | 2007 |
| The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial L Ma, X Hu, L Song, X Chen, M Ouyang, L Billot, Q Li, A Malavera, X Li, ... The Lancet 402 (10395), 27-40, 2023 | 109 | 2023 |
| Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset KJ Billingsley, IA Barbosa, S Bandrés-Ciga, JP Quinn, VJ Bubb, ... npj Parkinson's Disease 5 (1), 8, 2019 | 106 | 2019 |
| The promise of telemedicine for movement disorders: an interdisciplinary approach H Ben-Pazi, P Browne, P Chan, E Cubo, M Guttman, A Hassan, ... Current neurology and neuroscience reports 18, 1-10, 2018 | 97 | 2018 |
| Global survey on telemedicine utilization for movement disorders during the COVID‐19 pandemic A Hassan, Z Mari, EM Gatto, A Cardozo, J Youn, N Okubadejo, JA Bajwa, ... Movement Disorders 35 (10), 1701-1711, 2020 | 94 | 2020 |
| Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability RH Reynolds, J Botía, MA Nalls, J Hardy, SA Gagliano Taliun, M Ryten npj Parkinson's Disease 5 (1), 6, 2019 | 91 | 2019 |
| Clinical profile of parkinsonism and Parkinson's disease in Lagos, Southwestern Nigeria NU Okubadejo, OO Ojo, OO Oshinaike BMC neurology 10, 1-6, 2010 | 86 | 2010 |
| Dementia in Africa: Current evidence, knowledge gaps, and future directions RO Akinyemi, J Yaria, A Ojagbemi, M Guerchet, N Okubadejo, ... Alzheimer's & Dementia 18 (4), 790-809, 2022 | 78 | 2022 |
| Incidence and 30-day case fatality rate of first-ever stroke in urban Nigeria: the prospective community based Epidemiology of Stroke in Lagos (EPISIL) phase II results MA Danesi, NU Okubadejo, FI Ojini, OO Ojo Journal of the neurological sciences 331 (1-2), 43-47, 2013 | 77 | 2013 |
| Analysis of Nigerians with apparently sporadic Parkinson disease for mutations in LRRK2, PRKN and ATXN3 N Okubadejo, A Britton, C Crews, R Akinyemi, J Hardy, A Singleton, ... PLoS One 3 (10), e3421, 2008 | 74 | 2008 |
| Factors influencing non-compliance with anti-hypertensive drug therapy in Nigerians. CO Amira, NU Okubadejo National Postgraduate Medical College of Nigeria, 2007 | 71 | 2007 |
| PDXK mutations cause polyneuropathy responsive to pyridoxal 5′‐phosphate supplementation V Chelban, MP Wilson, J Warman Chardon, J Vandrovcova, MN Zanetti, ... Annals of neurology 86 (2), 225-240, 2019 | 69 | 2019 |
| Six action steps to address global disparities in Parkinson disease: a World Health Organization priority N Schiess, R Cataldi, MS Okun, N Fothergill-Misbah, ER Dorsey, ... JAMA neurology 79 (9), 929-936, 2022 | 66 | 2022 |
Frank OjiniProfessor of Medicine, University of Lagos在 unilag.edu.ng 的电子邮件经过验证
